Vimab Group OM:VIMAB Stock Report

Last Price

kr7.60

Market Cap

kr138.9m

7D

-2.1%

1Y

n/a

Updated

30 Nov, 2022

Data

Company Financials
VIMAB fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

VIMAB Stock Overview

VIMAB Holding AB was incorporated in 2017 and is based in Motala, Sweden.

Vimab Group AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Vimab Group
Historical stock prices
Current Share Pricekr7.60
52 Week Highkr10.80
52 Week Lowkr6.96
Beta0
1 Month Change-11.01%
3 Month Change-9.52%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-24.00%

Recent News & Updates

Recent updates

Shareholder Returns

VIMABSE Professional ServicesSE Market
7D-2.1%0.2%-0.1%
1Yn/a-24.5%-24.0%

Return vs Industry: Insufficient data to determine how VIMAB performed against the Swedish Professional Services industry.

Return vs Market: Insufficient data to determine how VIMAB performed against the Swedish Market.

Price Volatility

Is VIMAB's price volatile compared to industry and market?
VIMAB volatility
VIMAB Average Weekly Movement6.8%
Professional Services Industry Average Movement6.9%
Market Average Movement7.4%
10% most volatile stocks in SE Market12.5%
10% least volatile stocks in SE Market4.6%

Stable Share Price: VIMAB is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: Insufficient data to determine VIMAB's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2017n/an/a

VIMAB Holding AB was incorporated in 2017 and is based in Motala, Sweden.

Vimab Group AB (publ) Fundamentals Summary

How do Vimab Group's earnings and revenue compare to its market cap?
VIMAB fundamental statistics
Market Capkr138.88m
Earnings (TTM)kr0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
VIMAB income statement (TTM)
Revenuekr0
Cost of Revenuekr0
Gross Profitkr0
Other Expenseskr0
Earningskr0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did VIMAB perform over the long term?

See historical performance and comparison